Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer.

Published in:

Medicina (1010660X), 2024, v. 60, n. 6, p. 951, doi. 10.3390/medicina60060951

By:

• Kınıkoğlu, Oğuzcan;
• Odabas, Hatice;
• Altıntaş, Yunus Emre;
• Yıldız, Anıl;
• Çakan, Burçin;
• Akdağ, Goncagül;
• Yıldırım, Sedat;
• Bal, Hamit;
• Kaya, Tuğba;
• Tünbekici, Salih;
• Işık, Deniz;
• Başoğlu, Tuğba;
• Yıldırım, Mahmut Emre;
• Turan, Nedim

Publication type:

Article